Geneva Partners’s Marvell Technology MRVL Stock Holding History
Bought
Maintained
Sold
Other funds holding MRVL
Geneva Partners's MRVL Position: Q3 2026 in Review
Geneva Partners reduced its Marvell Technology (MRVL) stake by 40% in Q3 2026, selling an estimated $6.14M and leaving 40,657 shares worth $10.7M. The position accounts for 3.21% of the portfolio, ranked #8.
Geneva Partners first reported a position in MRVL in Q2 2020 and has held it in 3 quarters since. The position peaked at $20.3M in Q2 2026. 748 funds tracked by Wall St. Rank hold MRVL as of Q3 2026.
- Geneva Partners held 40,657 shares of Marvell Technology worth $10.7M as of Q3 2026.
- Geneva Partners sold 27,391 Marvell Technology shares in Q3 2026, an estimated $6.14M.
- Marvell Technology made up 3.21% of Geneva Partners's portfolio in Q3 2026, its #8 holding.
- Geneva Partners first reported a position in Marvell Technology in Q2 2020 and has held it in 3 quarters since.
- Geneva Partners's Marvell Technology position peaked at $20.3M in Q2 2026.
- 748 funds tracked by Wall St. Rank held Marvell Technology as of Q3 2026.
Based on Geneva Partners's 13F filing for Q3 2026, filed 26 Oct 2026.